KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PHG - US5004723038
28.07 USD
+0.22 (+0.79%)
28.08 USD
+0.01 (+0.04%)
We assign a fundamental rating of 4 out of 10 to PHG. PHG was compared to 188 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of PHG while its profitability can be described as average. PHG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHG was profitable.
In the past year PHG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 0.61%, PHG is doing good in the industry, outperforming 73.40% of the companies in the same industry.
The Return On Equity of PHG (1.56%) is better than 74.47% of its industry peers.
PHG's Return On Invested Capital of 4.49% is fine compared to the rest of the industry. PHG outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.49% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.91%, PHG is in the better half of the industry, outperforming 73.40% of the companies in the same industry.
Looking at the Operating Margin, with a value of 6.11%, PHG is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
PHG's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 43.85%, PHG is doing worse than 62.77% of the companies in the same industry.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHG is destroying value.
PHG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHG has more shares outstanding
The debt/assets ratio for PHG is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.93 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
PHG has a Altman-Z score of 1.93. This is comparable to the rest of the industry: PHG outperforms 59.57% of its industry peers.
The Debt to FCF ratio of PHG is 19.41, which is on the high side as it means it would take PHG, 19.41 years of fcf income to pay off all of its debts.
PHG's Debt to FCF ratio of 19.41 is fine compared to the rest of the industry. PHG outperforms 70.21% of its industry peers.
PHG has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHG is somewhat dependend on debt financing.
PHG's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHG is outperformed by 68.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.67
WACC6.67%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHG should not have too much problems paying its short term obligations.
PHG has a Current ratio of 1.26. This is amonst the worse of the industry: PHG underperforms 81.91% of its industry peers.
PHG has a Quick Ratio of 1.26. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG has a worse Quick ratio (0.81) than 84.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.15% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -0.81% in the last year.
PHG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
PHG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.65% yearly.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.42, PHG is valued correctly.
PHG's Price/Earnings ratio is rather cheap when compared to the industry. PHG is cheaper than 86.17% of the companies in the same industry.
When comparing the Price/Earnings ratio of PHG to the average of the S&P500 Index (25.98), we can say PHG is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 15.88, the valuation of PHG can be described as correct.
PHG's Price/Forward Earnings ratio is rather cheap when compared to the industry. PHG is cheaper than 85.64% of the companies in the same industry.
PHG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.42 | ||
| Fwd PE | 15.88 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHG is valued cheaper than 87.77% of the companies in the same industry.
73.94% of the companies in the same industry are more expensive than PHG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.92 | ||
| EV/EBITDA | 12.5 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)69.09
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.09%, PHG is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.73, PHG pays a better dividend. On top of this PHG pays more dividend than 98.94% of the companies listed in the same industry.
PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.09% |
5.2 History
The dividend of PHG decreases each year by -70.49%.
PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
0.62% of the earnings are spent on dividend by PHG. This is a low number and sustainable payout ratio.
DP0.62%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
28.07
+0.22 (+0.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner Change-2.3%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap27.03B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target31.98 (13.93%)
Short Float %0.26%
Short Ratio2.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.09% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.49%
PT rev (3m)0.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.42 | ||
| Fwd PE | 15.88 | ||
| P/S | 1.31 | ||
| P/FCF | 53.92 | ||
| P/OCF | 21.29 | ||
| P/B | 2.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.5 |
EPS(TTM)1.71
EY6.09%
EPS(NY)1.77
Fwd EY6.3%
FCF(TTM)0.52
FCFY1.85%
OCF(TTM)1.32
OCFY4.7%
SpS21.42
BVpS12.45
TBVpS-2.03
PEG (NY)69.09
PEG (5Y)N/A
Graham Number21.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.49% | ||
| ROICexc | 4.97% | ||
| ROICexgc | 16.33% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.93 |
F-Score8
WACC6.67%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NVR- NY / PHG FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PHG.
What is the valuation status for PHG stock?
ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NVR- NY?
KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.
What are the PE and PB ratios of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Price/Earnings (PE) ratio for KONINKLIJKE PHILIPS NVR- NY (PHG) is 16.42 and the Price/Book (PB) ratio is 2.25.
What is the expected EPS growth for KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 0.24% in the next year.